Weiwei Hu

635 total citations
21 papers, 463 citations indexed

About

Weiwei Hu is a scholar working on Rheumatology, Oncology and Molecular Biology. According to data from OpenAlex, Weiwei Hu has authored 21 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Weiwei Hu's work include Bone health and osteoporosis research (4 papers), Connective tissue disorders research (3 papers) and Bone health and treatments (2 papers). Weiwei Hu is often cited by papers focused on Bone health and osteoporosis research (4 papers), Connective tissue disorders research (3 papers) and Bone health and treatments (2 papers). Weiwei Hu collaborates with scholars based in China, Canada and United States. Weiwei Hu's co-authors include Zhenlin Zhang, Jie‐Mei Gu, Jin‐Wei He, Wen‐Zhen Fu, Hua Yue, Yun-qiu Hu, Chun Wang, Yaohua Ke, Hao Zhang and Miao Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The American Journal of Human Genetics and European Journal of Medicinal Chemistry.

In The Last Decade

Weiwei Hu

19 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Hu China 12 166 163 148 91 89 21 463
Mila Jhamai Netherlands 10 186 1.1× 88 0.5× 250 1.7× 204 2.2× 174 2.0× 13 612
Zihao Qu China 13 85 0.5× 105 0.6× 166 1.1× 31 0.3× 96 1.1× 22 489
Sarah Hardcastle United Kingdom 12 71 0.4× 163 1.0× 122 0.8× 59 0.6× 188 2.1× 19 522
Taichi Kitaoka Japan 16 349 2.1× 201 1.2× 273 1.8× 88 1.0× 87 1.0× 49 798
Ruth Herd New Zealand 4 137 0.8× 64 0.4× 266 1.8× 72 0.8× 291 3.3× 5 534
Mark E. Nuñes United States 12 211 1.3× 183 1.1× 202 1.4× 59 0.6× 64 0.7× 24 644
Maria Rosaria Povino Italy 9 86 0.5× 178 1.1× 119 0.8× 58 0.6× 173 1.9× 12 407
Arin K. Oestreich United States 11 104 0.6× 144 0.9× 135 0.9× 13 0.1× 77 0.9× 17 465
M. Carstens Denmark 12 142 0.9× 109 0.7× 407 2.8× 57 0.6× 318 3.6× 16 669
Dong-Hai Xiong China 18 367 2.2× 59 0.4× 371 2.5× 57 0.6× 247 2.8× 30 788

Countries citing papers authored by Weiwei Hu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Hu more than expected).

Fields of papers citing papers by Weiwei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Hu. The network helps show where Weiwei Hu may publish in the future.

Co-authorship network of co-authors of Weiwei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Hu. A scholar is included among the top collaborators of Weiwei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Hu. Weiwei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Weiwei, et al.. (2025). The performance of quantum battery in a common dephasing environment. Physica E Low-dimensional Systems and Nanostructures. 170. 116229–116229. 1 indexed citations
2.
Hu, Weiwei, et al.. (2025). Atypical clinical presentation associated with Castleman disease: a case report and review of the literature. Frontiers in Medicine. 12. 1626722–1626722.
4.
Liu, Zhikun, Guiyang Jiang, Meng Wang, et al.. (2023). Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis. European Journal of Medicinal Chemistry. 263. 115968–115968. 9 indexed citations
5.
Hu, Weiwei, Zhilong Dong, Junqiang Tian, et al.. (2022). The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 26(3). 483–494. 9 indexed citations
6.
Hu, Weiwei, et al.. (2020). Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules. Cellular Oncology. 43(5). 889–900. 27 indexed citations
7.
Wan, Jiangbo, Fang Huang, Weiwei Hu, & Siguo Hao. (2018). IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect. Biochemical and Biophysical Research Communications. 507(1-4). 122–127. 2 indexed citations
9.
Zhang, Hailong, Hua Yue, Juan Gu, et al.. (2016). Novel mutations in the SEC24D gene in Chinese families with autosomal recessive osteogenesis imperfecta. Osteoporosis International. 28(4). 1473–1480. 22 indexed citations
10.
Hu, Weiwei, Feng Jiang, Shifu Tang, et al.. (2013). Association between KCNQ1 genetic variants and QT interval in a Chinese population. Diabetic Medicine. 30(10). 1225–1229. 2 indexed citations
11.
Zhang, Hao, Qiren Huang, Jie‐Mei Gu, et al.. (2012). Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency. Acta Pharmacologica Sinica. 33(4). 490–495. 14 indexed citations
12.
Hu, Weiwei, Hao Zhang, Chun Wang, et al.. (2012). Lean Mass Predicts Hip Geometry and Bone Mineral Density in Chinese Men and Women and Age Comparisons of Body Composition. Journal of Clinical Densitometry. 15(4). 434–442. 23 indexed citations
13.
Zhang, Hao, Yaohua Ke, Chun Wang, et al.. (2012). Identification of the Mutations in the Tissue-nonspecific Alkaline Phosphatase Gene in Two Chinese Families with Hypophosphatasia. Archives of Medical Research. 43(1). 21–30. 14 indexed citations
14.
Zhang, Zhenlin, Weibo Xia, Jin‐Wei He, et al.. (2011). Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy. The American Journal of Human Genetics. 90(1). 125–132. 129 indexed citations
15.
Zhang, Zhenlin, Hao Zhang, Yaohua Ke, et al.. (2011). The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta. Journal of Bone and Mineral Metabolism. 30(1). 69–77. 61 indexed citations
16.
Zhang, Zhenlin, Jin‐Wei He, Hao Zhang, et al.. (2009). Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II). Journal of Bone and Mineral Metabolism. 27(4). 444–451. 25 indexed citations
17.
Zhang, Zhenlin, Hao Zhang, Weiwei Hu, et al.. (2008). Hip Axis Length Changes in 10,554 Males and Females and the Association with Femoral Neck Fracture. Journal of Clinical Densitometry. 11(3). 360–366. 40 indexed citations
18.
Hu, Weiwei, Xiujue Zheng, Gang Shen, et al.. (2007). [Diagnosis and micro-neurosurgery for the fourth cerebral ventricle tumors].. PubMed. 29(2). 144–6.
19.
Zhang, Zhenlin, Yuejuan Qin, Qiren Huang, et al.. (2006). Bone mineral density of the spine and femur in healthy Chinese men. Asian Journal of Andrology. 8(4). 419–427. 27 indexed citations
20.
Yang, Xiaofeng, Yao Yu, Weiwei Hu, et al.. (2005). Is decompressive craniectomy for malignant middle cerebral artery infarction of any worth?. Journal of Zhejiang University SCIENCE A. 6B(7). 644–649. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026